Antitumor effects of somatostatin
- 14 May 2008
- journal article
- review article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 286 (1-2), 230-237
- https://doi.org/10.1016/j.mce.2008.02.002
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2: Co-immunoprecipitation and fluorescence resonance energy transfer analysisCellular Signalling, 2007
- Complete, Long-Standing Regression of Hepatocellular Carcinoma After Somatostatin Analogue TreatmentJournal of Clinical Oncology, 2007
- SOM230, A New Somatostatin Analogue, Is Highly Effective in the Therapy of Growth Hormone/Prolactin-Secreting Pituitary AdenomasClinical Cancer Research, 2007
- Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathwayThe EMBO Journal, 2006
- Regulation of Neuronal Nitric-oxide Synthase Activity by Somatostatin Analogs following SST5 Somatostatin Receptor ActivationPublished by Elsevier BV ,2006
- Characterization of the Bystander Effect of Somatostatin Receptor sst2 AfterIn VivoGene Transfer into Human Pancreatic Cancer CellsHuman Gene Therapy, 2005
- Receptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin AnalogsMolecular Pharmacology, 2005
- Future Aspects of Somatostatin- Receptor-Mediated TherapyNeuroendocrinology, 2004
- Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell ProliferationMolecular Biology of the Cell, 2003
- Somatostatin and Its Receptor FamilyFrontiers in Neuroendocrinology, 1999